跳至主要内容
临床试验/NCT02874235
NCT02874235已完成不适用

Music Therapy Versus Treatment as Usual: A Randomized Non-inferiority Study With Traumatized Refugees Diagnosed With PTSD

Psychiatric Research Unit, Region Zealand, Denmark0 个研究点目标入组 74 人开始时间: 2016年5月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
74
主要终点
Change in HTQ-R

研究概览

简要总结

This study compares music therapy with verbal psychotherapy (treatment as usual) in an outpatient psychiatric clinic for traumatized refugees. Based on positive results from a pilot study, the randomized clinical trial has a non-inferiority design to detect whether music therapy is not less effective than verbal therapy carried out by psychologists and can serve as a complementary treatment modality (n=70).

The participants are adult Arabic, English or Danish speaking refugees suffering from posttraumatic stress disorder (PTSD). The patients are referred to outpatient treatment by their medical doctor. Data collection takes place in three locations of the clinic in Region Zealand, Denmark. The music therapy method used is Guided Imagery and Music (GIM).

Primary outcome is pre, post and 6 months follow-up measures of HTQ (Harvard Trauma Questionaire) and two measures of PTSD-8 during treatment. Secondary outcomes are pre, post and 6 months follow-up measures of Quality of Life Questionnaire (WHO-5), Dissociation Symptom Scale (DSS), Somatoform Dissociation Questionaire (SDQ-20), Revised Adult Attachment Scale (RAAS) and physiological measures (salivary oxytocin, betaendorphin and Substance P).

详细描述

Subjects are randomized to 16 sessions of trauma modified GIM or 16 sessions of verbal psychotherapy (standard treatment).

N (70) is based on a power calculation using HTQ measures from similar refugee studies, with an estimated effect size in the range 0.6-0.8.

Sampling All baseline measures are scored during interview with a therapist before randomization. The primary post and follow-up measures (HTQ-R) are scored during interviews conducted by external psychologists blinded to the treatment group. The secondary post and follow-up measures are self-report questionnaires scored by the patients with the help of an educated translator who is blinded with regards to the treatment group.

0.5 ml salivary samples are collected in plastic tubes and stored at -20 degrees C.

The concentration of tree hormones (oxytocin, betaendorphin, substance P) are analyzed in a multiplex solution.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

External psychologist performs primary outcome measurement not knowing participants treatment

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnostic Statistical Manual of Mental Disorders (DSM-5): Posttraumatic Stress Disorder Reaction: 309.81
  • Refugee status: Inhabitant in Denmark
  • International Classification of Diseases (ICD-10): F43.1: PTSD or
  • International Classification of Diseases (ICD-10): F62.0 Enduring personality change after catastrophic experience
  • Referred from a general practitioner or other unit of psychiatry

排除标准

  • International Classification of Diseases (ICD-10): F20-29 Schizophrenia or schizophrenia like diagnoses
  • Active Substance Abuse
  • Major Depression in connection with psychoses or suicidal risk

结局指标

主要结局

Change in HTQ-R

时间窗: 6 months

DSM IV PTSD symptoms part (first 16 items) of section 4 of HTQ. the Harvard Trauma Questionnaire is a 4 point Likert scale. Scored during an interview with an external psychologist blinded to the treatment group. Measured at baseline, post-treatment and at 6 months follow up.

Change in PTSD-8

时间窗: 6 months

DSM IV PTSD symptoms (8 of the first 16 items) of section 4 of HTQ. The Harvard Trauma Questionnaire is a Likert 4 point scale. PTSD is scored by the patient two times during treatment before session 4 and 12. This measure is also a part of the HTQ-R (Outcome 1)

次要结局

  • Change in RAAS(6 months)
  • Change in WHO-5(6 months)
  • Change in DSS(6 months)
  • Change in Oxytocin(6 months)
  • Change in Substance P(6 months)
  • Change in SDQ-20(6 months)
  • Change in Beta-endorphin(6 months)

研究者

发起方
Psychiatric Research Unit, Region Zealand, Denmark
申办方类型
Other
责任方
Sponsor

相似试验